OncWeekly Content Page - Page 14

Other Cancers

Ide-Cel vs Standard Regimens in High-Risk TCE RRMM

Dec 22, 2023

Other Cancers

Lower-Risk Myelofibrosis: Progression and Leukemic Transformation

Dec 22, 2023

Other Cancers

Reducing Dexamethasone Dose Impacts NDMM Patients

Dec 21, 2023

Other Cancers

Visugromab: Phase 2A Results in Advanced Solid Tumors

Dec 21, 2023

Advertisement

Other Cancers

Ide-cel Boosts Outcomes in Triple-Class Myeloma

Dec 20, 2023

Other Cancers

Ven vs. Bortezomib With Dd in T(11;14)-Positive R/R MM

Dec 20, 2023

Other Cancers

Tal + Dara Shows Promising Early Results in Resistant Myeloma

Dec 20, 2023

Other Cancers

Linvoseltamab 200MG for RRMM: LINKER-MM1 Analysis

Dec 19, 2023

Previous
1
…
12
13
14
15
16
…
66
Next

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Newsletter

Advertisement